序號(hào) | 藥品通用名稱 | 英文名稱/商品名 | 規(guī)格 | 劑型 | 持證商 | 備注1 | 備注2 | 信息來(lái)源 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4271 | 鹽酸文拉法辛緩釋片 | Venlafaxine Hydrochloride Sustained-release Tablets/-- | 75mg(按C17H27NO2計(jì)) | 片劑(緩釋片) | Osmotica Pharmaceutical Corp | 美國(guó)橙皮書 | 美國(guó)橙皮書收載名稱:Venlafaxine Hydrochloride Extended Release Tablets | 第八批 | |||||||||
4272 | 鹽酸文拉法辛緩釋片 | Venlafaxine Hydrochloride Sustained-release Tablets/-- | 37.5mg(按C17H27NO2計(jì)) | 片劑(緩釋片) | Osmotica Pharmaceutical Corp | 美國(guó)橙皮書 | 美國(guó)橙皮書收載名稱:Venlafaxine Hydrochloride Extended Release Tablets | 第八批 | |||||||||
4273 | 鹽酸文拉法辛片 | Venlafaxine Hydrochloride Tablets/-- | 50mg(按C17H27NO2計(jì)) | 片劑 | Teva Pharmaceuticals USA Inc | 美國(guó)橙皮書 | 第八批 | ||||||||||
4274 | 鹽酸文拉法辛片 | Venlafaxine Hydrochloride Tablets/-- | 25mg(按C17H27NO2計(jì)) | 片劑 | Teva Pharmaceuticals USA Inc | 美國(guó)橙皮書 | 第八批 | ||||||||||
4275 | 氯化鉀緩釋片 | Potassium Chloride Sustained-release Tablets/Slow-K | 600mg | 片劑 | Novartis Pharma K.K. | 日本橙皮書 | 日本橙皮書收載名稱:Potassium Chloride Extended Release Tablets | 第八批 | |||||||||
4276 | 氯化鉀緩釋片 | Potassium Chloride Sustained-release Tablets/KLOR-CON | 10MEQ(相當(dāng)于0.75g?氯化鉀) | 片劑 | UPSHER-SMITH LABORATORIES INC | 美國(guó)橙皮書 | 美國(guó)橙皮書收載名稱:Potassium Chloride Extended Release Tablets | 第八批 | |||||||||
4277 | 氯化鉀緩釋片 | Potassium Chloride Sustained-release Tablets/KLOR-CON | 8MEQ(相當(dāng)于0.6g氯化鉀) | 片劑 | UPSHER-SMITH LABORATORIES INC | 美國(guó)橙皮書 | 美國(guó)橙皮書收載名稱:Potassium Chloride Extended Release Tablets | 第八批 | |||||||||
4278 | 鹽酸利托君片 | Ritodrine Hydrochloride Tablets/ Utemerin | 5mg | 片劑 | Kissei Pharmaceutical Co., Ltd. | 日本橙皮書 | 第八批 | ||||||||||
4279 | 羥基脲膠囊 | Hydroxyurea Capsules/ Hydrea | 500mg | 膠囊劑 | BRISTOL MYERS SQUIBB CO | 美國(guó)橙皮書 | 第八批 | ||||||||||
4280 | 枸櫞酸鉍鉀片 | Bismuth Potassium Citrate Tablets/GASTRODENOL | 120mg(以Bi2O3計(jì)) | 片劑 | Tora Laboratories S.L. | 歐盟上市(產(chǎn)地:西班牙;上市國(guó)家:西班牙) | 西班牙文名稱:SUBCITRATO de BISMUTO COLOIDAL | 第八批 |
You are welcome to contact us via the online form below.
We will answer your inquiries in various ways, and jointly provide customized professional consultation and solutions for your research and development needs.